Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
24
RAFA Quote, Financials, Valuation and Earnings
Last price:
$0.0300
Seasonality move
:
-4.21%
Day range:
$0.0036 - $0.0386
52-week range:
$0.0036 - $0.1790
Dividend yield:
0%
P/E ratio:
14.12x
P/S ratio:
0.26x
P/B ratio:
0.22x
Volume:
2K
Avg. volume:
21.3K
1-year change:
-72.65%
Market cap:
$2.3M
Revenue:
$9.1M
EPS (TTM):
--
Earnings Data
Next earnings date for RAFA
--
Most recent earnings per share
$0.00
Beat by $0.00
(May 21/2025)
Consensus Estimate
--
(May 21/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RAFA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/21/2025 | Q1 | -- | $278K | $0.00 | -- | -- |
| 12/31/2024 | Q4 | -- | $8.6M | $0.00 | -- | -- |
| 09/30/2024 | Q3 | -- | $185K | $0.00 | -- | -- |
Rafarma Pharmaceuticals, Inc. Earnings Questions
-
How Much did Rafarma Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Rafarma Pharmaceuticals, Inc. reported $278K worth of top line sales in its most recent quarter.
-
Did Rafarma Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Rafarma Pharmaceuticals, Inc. announced earnings per share of $0.00 which represents a beat of analyst forecast a -- per share.
-
Is Rafarma Pharmaceuticals, Inc. Profitable?
Rafarma Pharmaceuticals, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Rafarma Pharmaceuticals, Inc. EPS Next Year?
Rafarma Pharmaceuticals, Inc.'s earnings are forecast to grow from $0.00 per share to -- per share next year representing an increase of --.
-
When is Rafarma Pharmaceuticals, Inc.'s Earnings Date?
Currently, Rafarma Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 6, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
45
CTEV alert for Jan 4
Claritev Corp. [CTEV] is down 20.7% over the past day.
Buy
60
BIDU alert for Jan 3
Baidu, Inc. [BIDU] is up 15.01% over the past day.
Sell
47
ASTS alert for Jan 4
AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.
